Crohn's disease (CD)
Chronic inflammatory demyelinating polyneuropathy-like neuropathy as an initial presentation of Crohn’s disease
... and CD occurred at the same time, but the patients had only one acute pro- gressive symptom, which was not differentiated from acute inflammatory demyelinating polyradiculoneuropathy (AIDP) ...Crohn’s ...
5
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
... The main characteristics of the included 20 studies [9, 10, 13, 16, 27–42] are detailed in Tables 1 and 2. The included two Park et al. studies [32, 37] and two Cho et al. studies [33, 38] were not duplicated. Among the ...
15
Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn’s disease: correlation with SES-CD and clinical-biological markers
... long-term disease out- come in ...assessing disease remission in CD, and in the present study we prefer to use the SES-CD since it is a reproducible index for this evaluation [13, 21], easier ...
9
Mean platelet volume: a controversial marker of disease activity in Crohn’s disease
... 61 CD patients and 50 healthy subjects. Disease activity was assessed by the Crohn ’ s Disease Activity ...with CD compared with healthy controls (P ...inactive CD groups. ...
7
Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn’s disease
... early-diagnosed CD were enrolled in the study. Early-diagnosed CD was defined as follows: (i) diagnosis within the past 2years, (ii) patients with CD and a past history of surgery and endoscopic ...
7
Feasibility of high-intensity interval training and moderate-intensity continuous training in adults with inactive or mildly active Crohn’s disease: study protocol for a randomised controlled trial
... active Crohn ’ s disease will be randomly assigned 1:1:1 to HIIT, MICT or usual care ...of disease activity (faecal calprotectin and Crohn ’ s Disease Activity Index) and ...
9
The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn’s disease
... ELISA measurements of serum AIM and ASCA levels We measured the serum AIM concentrations in 90 pa- tients with IBD, 17 with BD, and 16 heathy individuals as described above. AIM levels were determined using ELISA kits ...
9
Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn’s disease
... transmural disease ac- tivity in colonic CD nor that a single FCP measurement is sufficient for precise evaluation of colonic mucosal disease ...colonic CD with colonoscopy and ...
9
Systemic lupus erythematosus complicated by Crohn’s disease: a case report and literature review
... examination, biopsy showed only mild inflammation and revealed neither granuloma nor crypt abscess. The patient underwent surgery for anal fistulas twice at 50 and 54 years of age and her symptoms were atypical of lupus ...
5
Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn’s disease
... bowel disease was used to identify newly diagnosed children with CD from 2011 to ...of disease location, serial weight and height measurements, and details of standard inflammatory markers such as ...
9
Successful treatment of rectovaginal fistula and rectal stenosis due to perianal Crohn’s disease by dual-port laparoscopic abdominoperineal resection: a report of two cases
... A 33-year old woman was diagnosed with small intes- tinal and colonic CD 14 years earlier. Six years ago, she underwent ileocecal resection for stenosis of the ileum. After surgery, she was started on infliximab ...
6
Interleukin-32: its role in asthma and potential as a therapeutic agent
... ’ s disease; CCL: CC chemokine ligand; CD: Crohn ’ s disease; COPD: Chronic obstructive pulmonary disease; DCs: Dendritic cells; ELISA: Enzyme-linked immunosorbent assay; ...
7
Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
... of disease activity/bio- markers at start of the adalimumab therapy and during follow-up) was applied as requested by the Hungarian Na- tional Health Fund ...injection. Disease location and disease ...
7
Risk factors for 90-day readmission in veterans with inflammatory bowel disease—Does post-discharge follow-up matter?
... IBD diagnosis was based on the international classifica- tion of diseases, Ninth Revision codes for ulcerative colitis (UC) or Crohn’s disease (CD) (ICD codes 556.X and 555.X, respectively) and ...
6
Fibroblast growth factor 23 contributes to diminished bone mineral density in childhood inflammatory bowel disease
... Results: Low BMD was frequent during IBD flare (87.2%) with significant improvement after remission (44.7%). During disease flare, only 21.3% of patients had vitamin D deficiency, which was severe in 12.8%. During ...
8
Case report of cryptogenic multifocal ulcerous stenosing enteritis (CMUSE): a rare disease may contribute to endoscopy-capsule retention in the small intestine
... this disease remains difficult due to the lack of specific characteristics and the lesion mainly lo- cated in the small ...includes Crohn ’ s disease (CD) [14, 15], NSAIDs-induced ...
6
Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey
... bowel disease (IBD) includes ulcerative colitis (UC) and Crohn’s disease (CD), which are chronic inflammatory diseases of the gastrointestinal ...a disease primarily occurring in Wes- tern ...
7
Crohn’s disease in women
... Crohn’s disease (CD). High incidence of the new onset of the disease in young women in their reproductive years demands special concern from physicians involved in their ...with CD are ...
8
Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial
... Crohn’s Disease Activity Index (CDAI) [25] for those with CD or the Simple Clinical Colitis Activity Index (SCCAI) [26] for those with UC as ...appropriate. Disease activity was also monitored using ...
12
PubMedCentral-PMC5685845.pdf
... in Crohn’ s disease (CD), the long-term efficacy and safety of endoscopic balloon dilation (EBD) in CD strictures and its impact on the diagnosis of subclinical postoperative endoscopic ...
11